EP2672985
Sítratlausar lyfjasamsetningar sem innihalda anakinra
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
9.2.2012EP published:
27.4.2016EP application number:
12744410.7
EP translation filed:
7.7.2016Grant published:
15.8.2016EPO information:
European Patent Register
Max expiry date:
8.2.2032Expiry date:
8.2.2026Next due date:
28.2.2026
Title:
CITRATE FREE PHARMACEUTICAL COMPOSITIONS COMPRISING ANAKINRA
Timeline
Today
9.2.2012EP application
27.4.2016EP Publication
7.7.2016Translation submitted
15.8.2016Registration published
8.2.2026Expires
Owner
Name:
Swedish Orphan Biovitrum AB (Publ)Address:
112 76 Stockholm, SE
Inventor
Name:
FLORIN-ROBERTSSON, EbbaAddress:
S-113 27 Stockholm, SE
Name:
FRANSSON, JonasAddress:
S-752 38 Uppsala, SE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
1150109Date:
11.2.2011Country:
SE
Classification
Categories:
A61K 38/20, A61K 9/08, A61K 38/17, A61K 9/10, A61K 47/02, A61K 47/26, A61P 29/00
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 25.1.2017
Expires: 8.2.2018
Payer: Árnason Faktor
Number: 7
Paid: 8.2.2018
Expires: 8.2.2019
Payer: Árnason Faktor
Number: 8
Paid: 15.1.2019
Expires: 8.2.2020
Payer: Árnason Faktor
Number: 9
Paid: 15.1.2020
Expires: 8.2.2021
Payer: Árnason Faktor ehf.
Number: 10
Paid: 15.1.2021
Expires: 8.2.2022
Payer: Árnason Faktor ehf.
Number: 11
Paid: 21.1.2022
Expires: 8.2.2023
Payer: Árnason Faktor ehf.
Number: 12
Paid: 16.1.2023
Expires: 8.2.2024
Payer: Árnason Faktor ehf.
Number: 13
Paid: 19.2.2024
Expires: 8.2.2025
Payer: Árnason Faktor ehf.
Number: 14
Paid: 20.1.2025
Expires: 8.2.2026
Payer: Árnason Faktor ehf.